Literature DB >> 28801818

[Branch duct intraductal papillary mucinous neoplasm - surgical approach].

J Kaiser1, M W Büchler1, T Hackert2.   

Abstract

Due to increasing precision of modern imaging modalities, intraductal papillary mucinous neoplasms (IPMN) of the pancreas are found with increasing prevalence. Despite their malignant potential IPMN are often kept under surveillance and are not immediately resected. The 2012 International Consensus Guidelines of Fukuoka have been widely accepted for the management of IPMN. They recommend surgical resection for branch duct IPMN with "high risk stigmata", while branch duct IPMN with "worrisome features" should undergo observation without immediate resection. Consequently, patients with asymptomatic branch duct IPMN and a presumed low malignant potential mostly undergo primary surveillance to avoid surgery-related morbidity and mortality following pancreatic resection; however, with respect to the cumulative risk of malignant transformation over time, surgical resection might also be indicated for patients with branch duct IPMN with "worrisome features". This article discusses the indications for surgery and different options of resection of branch duct IPMN.

Entities:  

Keywords:  Branch duct IPMN; Fukuoka criteria; Indications; Observation; Parenchyma sparing resection

Mesh:

Year:  2017        PMID: 28801818     DOI: 10.1007/s00104-017-0491-3

Source DB:  PubMed          Journal:  Chirurg        ISSN: 0009-4722            Impact factor:   0.955


  38 in total

1.  Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series.

Authors:  Klaus Sahora; Mari Mino-Kenudson; William Brugge; Sarah P Thayer; Cristina R Ferrone; Dushyant Sahani; Martha B Pitman; Andrew L Warshaw; Keith D Lillemoe; Carlos F Fernandez-del Castillo
Journal:  Ann Surg       Date:  2013-09       Impact factor: 12.969

Review 2.  Postoperative care following pancreatic surgery: surveillance and treatment.

Authors:  Volker Keim; Ernst Klar; Michael Poll; Michael H Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2009-11-27       Impact factor: 5.594

3.  Does preoperative cross-sectional imaging accurately predict main duct involvement in intraductal papillary mucinous neoplasm?

Authors:  M R Barron; A M Roch; J A Waters; J A Parikh; J M DeWitt; M A Al-Haddad; E P Ceppa; M G House; N J Zyromski; A Nakeeb; H A Pitt; C Max Schmidt
Journal:  J Gastrointest Surg       Date:  2014-01-09       Impact factor: 3.452

4.  Pancreatic cysts: depiction on single-shot fast spin-echo MR images.

Authors:  Xiao-Ming Zhang; Donald G Mitchell; Masako Dohke; George A Holland; Laurence Parker
Journal:  Radiology       Date:  2002-05       Impact factor: 11.105

Review 5.  [Developments in pancreatic surgery during the past ten years].

Authors:  T Hackert; C Tjaden; M W Büchler
Journal:  Zentralbl Chir       Date:  2013-07-03       Impact factor: 0.942

6.  Pancreatic enucleation: improved outcomes compared to resection.

Authors:  C E Cauley; H A Pitt; K M Ziegler; A Nakeeb; C M Schmidt; N J Zyromski; M G House; K D Lillemoe
Journal:  J Gastrointest Surg       Date:  2012-04-24       Impact factor: 3.452

7.  Changing incidence of pancreatic neoplasms: a 16-year review of statewide tumor registry.

Authors:  Timothy L Fitzgerald; Zach J Hickner; Matthew Schmitz; Eric J Kort
Journal:  Pancreas       Date:  2008-08       Impact factor: 3.327

Review 8.  An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.

Authors:  Ralph H Hruban; Kyoichi Takaori; David S Klimstra; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Sandra A Biankin; Carolyn Compton; Noriyoshi Fukushima; Toru Furukawa; Michael Goggins; Yo Kato; Gunter Klöppel; Daniel S Longnecker; Jutta Lüttges; Anirban Maitra; G Johan A Offerhaus; Michio Shimizu; Suguru Yonezawa
Journal:  Am J Surg Pathol       Date:  2004-08       Impact factor: 6.394

9.  Small (Sendai negative) branch-duct IPMNs: not harmless.

Authors:  Stefan Fritz; Miriam Klauss; Frank Bergmann; Thilo Hackert; Werner Hartwig; Oliver Strobel; Bogata D Bundy; Markus W Büchler; Jens Werner
Journal:  Ann Surg       Date:  2012-08       Impact factor: 12.969

10.  Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.

Authors:  Taylor A Sohn; Charles J Yeo; John L Cameron; Ralph H Hruban; Noriyoshi Fukushima; Kurtis A Campbell; Keith D Lillemoe
Journal:  Ann Surg       Date:  2004-06       Impact factor: 12.969

View more
  2 in total

Review 1.  [Pancreatic cystic space-occupying lesions-Diagnostics, treatment and follow-up care : Current recommendations taking the current German S3 guidelines on pancreatic cancer into account].

Authors:  Maximilian Brunner; Lena Häberle; Irene Esposito; Robert Grützmann
Journal:  Chirurg       Date:  2022-03-22       Impact factor: 0.955

2.  Management and outcomes of intraductal papillary mucinous neoplasms.

Authors:  J Hipp; S Mohamed; J Pott; O Sick; F Makowiec; U T Hopt; S Fichtner-Feigl; U A Wittel
Journal:  BJS Open       Date:  2019-03-21
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.